 ImmuCell NASDAQ: ICCC is one of 25 publicly-traded companies in the Diagnostic substances industry, but how does it weigh in compared to its rivals? We will compare ImmuCell to related companies based on the strength of its analyst recommendations, institutional ownership, risk, dividends, earnings, valuation and profitability. Analyst Ratings This is a breakdown of recent ... 